Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

BACKGROUND: Rotaviruses are the most important cause of severe acute gastroenteritis worldwide in children <5 years of age. The human, G1P[8] rotavirus vaccine Rotarix™ significantly reduced severe rotavirus gastroenteritis episodes in a Phase III clinical trial conducted in infants in South Afri...

Descripción completa

Detalles Bibliográficos
Autores principales: Steele, Andrew Duncan, Neuzil, Kathleen M, Cunliffe, Nigel A, Madhi, Shabir A, Bos, Pieter, Ngwira, Bagrey, Witte, Desiree, Todd, Stacy, Louw, Cheryl, Kirsten, Mari, Aspinall, Sanet, Van Doorn, Leen Jan, Bouckenooghe, Alain, Suryakiran, Pemmaraju V, Han, Htay Htay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462149/
https://www.ncbi.nlm.nih.gov/pubmed/22974466
http://dx.doi.org/10.1186/1471-2334-12-213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462149/
https://www.ncbi.nlm.nih.gov/pubmed/22974466
http://dx.doi.org/10.1186/1471-2334-12-213

Ejemplares similares